Molecular Characterization of trans -Golgi p230: a human peripheral membrane protein encoded by a gene on chromosome 6p12-22 contains extensive coiled-coil α-helical domains and a Granin Motif by Erlich, Rebecca et al.
Molecular Characterization of trans-Golgi p230
A HUMAN PERIPHERAL MEMBRANE PROTEIN ENCODED BY A GENE ON CHROMOSOME 6p12–22
CONTAINS EXTENSIVE COILED-COIL a-HELICAL DOMAINS AND A GRANIN MOTIF*
(Received for publication, October 3, 1995, and in revised form, December 28, 1995)
Rebecca Erlich, Paul A. Gleeson, Paul Campbell‡§, Erin Dietzsch¶, and Ban-Hock Tohi
From the Department of Pathology and Immunology, Monash University Medical School, Melbourne, Victoria 3181,
Australia, the ‡Department of Clinical Immunology, Flinders Medical Center, Bedford Park, South Australia, and the
¶Department of Medical Biochemistry, University of Cape Town Medical School, Observatory, Cape Town 7925,
South Africa
Using autoantibodies from a Sjögren’s syndrome pa-
tient, we have previously identified a 230-kDa periph-
eral membrane protein associated with the cytosolic
face of the trans-Golgi (Kooy, J., Toh, B. H., Pettitt, J. M.,
Erlich, R. and Gleeson, P. A. (1992) J. Biol. Chem. 267,
20255–20263). Here we report the molecular cloning and
sequence analysis of human p230 and the localization of
its gene to chromosome 6p12–22. Partial cDNA clones,
isolated from a HeLa cell cDNA library using autoanti-
bodies, were used to obtain additional cDNAs, which
together span 7695 base pairs (bp). The p230 mRNA is
;7.7 kilobases. Two alternatively spliced mRNAs for
p230 were detected. These differed by 21- and 63-bp in-
sertions in the 3*-sequence, resulting in differences in
amino acid sequence at the carboxyl terminus. The pre-
dicted 261-kDa protein is highly hydrophilic with 17–
20% homology withmany proteins containing coiled-coil
domains. Apart from two proline-rich regions (amino
acids 1–117 and 239–270), p230 contains a very high fre-
quency of heptad repeats, characteristic of a-helices
that form dimeric coiled-coil structures. p230 also in-
cludes the sequence ESLALEELEL (amino acids 538–
546), a motif found in the granin family of acidic pro-
teins present in secretory granules of neuroendocrine
cells. This is the first report of a cytosolic Golgi protein
containing a granin motif. The structural characteris-
tics of p230 indicate that it may play a role in vesicular
transport from the trans-Golgi.
The Golgi apparatus is a highly complex and dynamic or-
ganelle organized into three functionally distinct regions: the
cis, medial, and trans cisternae of the Golgi stack and two
tubulovesicular networks, namely the cis-Golgi network and
the trans-Golgi network (1, 2). Transport of newly synthesized
proteins from the endoplasmic reticulum to Golgi cisternae,
between adjacent cisternae, and from the cisternae to various
destinations is mediated by vesicles shuttling between donor
and recipient compartments (3). Numerous structural and reg-
ulatory proteins have been implicated in the budding, docking,
and fusion of vesicles (3–5).
Soluble proteins involved in budding of vesicles include COPI
and COPII coat proteins and the small GTP binding protein
ARF-1. A N-ethylmaleimide-sensitive fusion protein, soluble
N-ethylmaleimide-sensitive fusion protein attachment pro-
teins (SNAPs)1 and Rabs are involved in either vesicle docking
or membrane fusion (3, 6–8). SNAP receptors (SNAREs), mem-
brane proteins that form oligomeric complexes with SNAPs and
N-ethylmaleimide-sensitive fusion proteins, are considered to
promote fusion of vesicles with target membranes after specific
docking mediated by SNAREs on vesicle and target membranes
(3). However, many facets of the transport process remain
unresolved. For example, the protein coat structures that me-
diate forward vesicle transport from the Golgi apparatus have
not been fully characterized.
Additional peripheral membrane Golgi proteins have also
been implicated in vesicular transport, for example three high
molecular weight proteins in cis to medial Golgi transport (9).
One of these, p115, contains coiled-coil domains and is related
to Uso1p required for transport from endoplasmic reticulum to
Golgi complex in Saccharomyces cerevisiae (10). Two peripheral
membrane proteins have been implicated in budding of vesicles
from the trans-Golgi network, namely p200, which associates
with coated vesicles arising from the trans-Golgi network (11),
and p62, which forms a complex with TGN38/41 and Rab6 (12).
Human autoantibodies are valuable reagents for identifica-
tion of novel intracellular proteins. Using anti-Golgi autoanti-
bodies from a patient with Sjögren’s syndrome, we have previ-
ously identified a brefeldin A-sensitive peripheral membrane
protein of 230 kDa (p230) localized to the cytosolic face of
trans-Golgi (13). Other novel Golgi proteins have also been
identified using autoantibodies, including golgins-95 and -160
(14), a protein of ;370 kDa (15, 16), which appears to be
identical to giantin (17), and a cis-Golgi network p210 protein
(18). For those Golgi proteins where sequences are known, a
common structural feature is a high content of predicted coiled-
coil domains. Here we have cloned and sequenced p230. The
predicted protein consists of a-helical coiled-coil domains with
abundant heptad repeats and contains a granin motif shared
with proteins found in secretory vesicles. We propose that p230
has a role in membrane transport of proteins from the Golgi
apparatus.
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Autoimmune Sera—Autoimmune sera were obtained from Gribbles
Pathology (Melbourne, Australia). Sera were treated at 56 °C for 30 min
to inactivate complement, and aliquots in 0.02% sodium azide were
stored at 270 °C.
Immunofluorescence—Indirect immunofluorescence using human
Hep2 cells (Kallstead) was performed as described previously (13).
Immunoblotting—Immunoblotting of HeLa cell extracts and recom-
binant p230 bacterial fusion protein was performed as described
previously (13).
Isolation and Sequencing of cDNA Clones—105 recombinants of a
lgt11 HeLa cell cDNA library (Clontech HL1022) were immuno-
screened with autoimmune serum from a Sjögren’s syndrome patient
diluted 1:1000 in phosphate-buffered saline (PBS) as described previ-
ously (13). Positive plaques, detected with 125I-labeled protein A, were
rescreened and plaque-purified. These cDNA clones were subcloned
into pBluescribe M131 (Stratagene) for sequencing. Additional cDNA
clones were obtained by subsequently screening a lZAP Hepatoma
cDNA library (Stratagene 935202) with 32P-labeled cDNA probes. Pos-
itive plaques were purified, and plasmids were rescued according to the
manufacturer’s instructions. The 32P-labeled cDNA probes were derived
initially from the lgt11 clones and subsequently from lZAP clones. In
addition, a 32P-labeled 45-mer based on sequence from a lZAP cDNA
clone was constructed from partially overlapping 30-mers, 59-GAGCTA-
ATCAACATTAGTAGTAGTAAAACT-39 and 59-AGAAAGAATGGCAT-
TAGTTTTACTACTACT-39 by a method described by Alderuccio et al.
(19). Finally, a random-primed HeLa cell cDNA library in pUEX (20)
was screened with a 32P-labeled 240-bp fragment obtained by PCR
using a lZAP clone as template. Nucleotide sequence of cDNA clones
clone was determined by the dideoxy method, using a deaza reagent
sequencing kit (Promega) in conjuction with T7 DNA polymerase (Phar-
macia Biotech Inc.) or by automated sequencing using a Prism
DyeDeoxy terminator cycle kit and a 373A DNA sequencer (Applied
Biosystems).
Elution of Antibody from l Plaques—To induce the expression of
b-galactosidase fusion protein, nitrocellulose filters impregnated with
10 mM isopropyl-1-thio-b-D-galactopyranoside were overlaid on agar
plates containing lgt11 plaques for 3 h at 42 °C. The filters were then
washed in PBS, blocked in 3% casein, and incubated with autoimmune
serum, diluted 1:1000 in PBS, for 1 h at room temperature. After
washing in PBS, the bound antibodies were eluted from the filters by
gently rocking in 3 M KSCN. The eluate was dialyzed overnight in PBS
and concentrated approximately 20-fold using Centricon filters
(Amicon).
Reverse Transcriptase Polymerase Chain Reaction—Total RNA was
isolated from HeLa cells by guanidium thiocyanate extraction followed
by ultracentrifugation in cesium chloride (21). After centrifugation, the
RNA pellets were resuspended in formamide for storage and precipi-
tated in four volumes of ethanol before use (22). HeLa cell RNA (2 mg)
was heated to 70 °C for 2 min, and cDNA was synthesized using 5 mg/ml
oligo(dT) (Promega) and 100 units of murine superscript reverse tran-
sriptase (Life Technologies, Inc.) in 50 mM KCl, 10 mM Tris-HCl, pH 8.3,
4 mM MgCl2, 0.01% gelatin, 1 mM of each of the four deoxynucleotide
triphosphates (Pharmacia), and 20–40 units of RNAsin (Promega) at
37 °C for 2 h. Reactions were also carried out without reverse tran-
scriptase or without RNA. Half of the volume of these reactions was
used as templates for PCR. Oligonucleotide primers were used at 0.2
pmol/ml in the presence of 10 mM Tris-Cl, pH 8.3, 50 mM KCl, 1.5 mM
MgCl2, 0.01% gelatin, 0.2 mM of each of the four deoxynucleotide
triphosphates, 2.5 units of Taq polymerase (Life Technologies, Inc.),
and 0.016 units of cloned Pfu DNA polymerase (Stratagene). The oligo-
nucleotide primers (produced by Department of Microbiology, Monash
University or by Bresatec, Adelaide, Australia) were as follows: P1
(59-GCTCTAGATCAAGGAGGAGACGGCGA-39), P2 (59-CCTCAGTAA-
GACTTTCTA-39), P3 (59-CCCAAGTCTATGAGTCCA-39), P4 (59-
GCGTCGACCACTGCCAACAATCACAG-39), and P5 (59-TTGGTC-
CAACCCAAATTG-39). Cycle conditions for P1/P2 and P4/P5 were as
follows: 1 cycle of 5 min at 95 °C, 1.5 min at 55 °C, and 3 min at 72 °C
and 29 cycles of 1.5 min at 95 °C, 1.5 min at 55 °C, and 3 min at 72 °C.
Cycle conditions for P3/P4 were as above except that the annealing
temperature was 60 °C.
Southern Blot Analysis—PCR products were separated by agarose
gel electrophoresis and then transfered to nylon membranes (Hybond-
N1, Amersham Corp.) in 0.4 M NaOH for 4 h. Membranes were then
incubated with prehybridization buffer (0.9 M NaCl, 90 mM
Na3C6H5O7.2H2O, 10 mM EDTA, pH 7.0, 7% SDS, and 0.5% skim milk
powder) for 30 min at 65 °C and hybridized overnight at 65 °C with
32P-labeled DNA (specific activity, .5 3 108 cpm/mg) in prehybridiza-
tion buffer. Membranes were washed at 65 °C in 0.15 M NaCl, 0.015 M
Na3C6H5O7z2H2O, pH 7.0, containing 0.1% SDS and exposed to x-ray
film (Fuji, Ashigara, Japan).
Northern Blot Analysis—- Total RNA was prepared from HeLa cells
as described above and enriched for poly(A)1 RNA by oligo(dT)-cellulose
chromatography using a poly(A) tract mRNA isolation system (Pro-
mega). Poly(A)1 RNA was separated by electrophoresis on 1% agarose
formaldehyde gel and transferred to nylon membranes (Hybond-N1,
Amersham Corp.) in 0.05 M NaOH for 2 h. After transfer, lanes con-
taining RNA markers were cut into strips and stained in methylene
blue (21). The remaining membrane was incubated with 32P-labeled
DNA probes as described for Southern analysis. The membranes were
stripped for reprobing by the addition of 0.5% SDS at 100 °C followed by
cooling to room temperature. The removal of the 32P-labeled probe was
confirmed by autoradiography.
Sequence Analysis—Analyses were carried out using the MacVector
program (International Biotechnologies, Inc) or using on-line software
provided by the Australian National Genome Information Service in-
cluding the FASTA program, (23), the pattern library search program of
Smith and Smith (24), and various programs contained in the Univer-
sity of Wisconsin GCG package (25). Coiled-coil structures were pre-
dicted using the method of Lupas et al. (26) using the STRIPE program
for the Macintosh.2
Chromosome in Situ Hybridization—Human chromosome met-
aphase spreads were obtained from PHA-stimulated peripheral blood
lymphocyte cultures synchronized with fluorodeoxyuridine (28) accord-
ing to standard cytogenetic procedures. The method of in situ hybrid-
ization was modified from Harper and Saunders (29) and Choo et al.
(30). The lg5 clone, labeled by random priming using [3H]dATP,
[3H]dCTP, and [3H]dTTP to a specific activity of 2.04 3 108 cpm/mg
DNA was added to the hybridization solution and hybridized to chro-
mosome preparations overnight at 40 °C. After washes in 0.15 M NaCl,
0.015 M Na3C6H507z2H20, pH 7.0, at 42 °C, slides were dipped in EM-1
hypercoat nuclear emulsion (Amersham Corp.) and exposed for 8–33
days at 4 °C. Autoradiographs were developed, and chromosomes were
G-banded in 2–5% Gurr’s improved R66 Giemsa stain (Merck, Kilsyth,
Australia) in 0.15 M Na2HPO4, pH 11, for 8 min (31). The distribution of
silver grains over chromosomes was analyzed.
RESULTS
Isolation and Characterization of cDNA Clones—We have
identified two autoimmune sera that show strong staining of
the Golgi apparatus by immunofluorescence (Fig. 1) and that
immunoblot a 230-kDa protein in HeLa cell extracts (Fig. 2).
One of these sera (autoimmune serum 1), from a patient with
Sjögren’s syndrome (13), has high titre anti-Golgi autoantibod-
ies by immunofluorescence (1:100,000) as well as lower titre
(1:20,000) antinuclear antibodies. Immunoscreening a HeLa
cell lgt11 cDNA expression library with diluted Sjögren’s syn-
drome autoimmune serum yielded four clones designated lg2,
lg5, lg7, and lg12 (Fig. 3). Autoantibodies eluted from nitro-
cellulose lifts of purified phage from each of the four clones
showed immunofluorescence staining of the Golgi apparatus,
whereas elution of bound antibodies from an irrelevant clone
showed no staining (Fig. 1). Furthermore, the eluted autoanti-
bodies showed no nuclear staining. These results indicate that
all four clones encode Golgi-associated proteins. Clone lg5 was
used to generate a bacterial fusion protein, using the expres-
sion vector pGEX (13). The two autoimmune sera specifically
reacted with the 51-kDa glutathionine S-transferase fusion
protein by immunoblotting (Fig. 2; see also Ref. 13). As re-
ported previously (13), affinity-purified Sjögren’s syndrome au-
toantibody eluted from the 51-kDa recombinant fusion protein
not only reacted with the Golgi apparatus in HeLa cells by
immunofluorescence but also immunoprecipitated and immu-
noblotted a 230-kDa protein; furthermore, a rabbit antibody
raised to the 51-kDa fusion protein gave specific immunofluo-
rescence of the Golgi apparatus and immunoblotted and immu-
noprecipitated the 230-kDa protein. These results confirm that
2 A. C. E. Knight, unpublished results.


























clone lg5 encodes a polypeptide derived from p230.
The four clones (lg2, lg5, lg7, and lg12) showed an overlap-
ping nucleotide sequence spanning approximately 2.0 kb (Fig.
3). To obtain additional sequence, we recreened a lZAP cDNA
hepatoma library using clone lg5 as probe. Two further clones,
designated lz2 and lz6, were isolated (Fig. 3). Further screen-
ing of the same library with lz6 resulted in clones lz7a and
lz8a. These latter clones also gave positive hybridization sig-
nals with clone lg5, and DNA sequencing confirmed their over-
lapping sequence. Screening the lZAP hepatoma library with a
300-bp HincII fragment of lg7 identified clones lz7, lz8, and
lz16, and screening with a 45-bp segment of lz6 identified lz9
(Fig. 3). The 59-sequence was obtained from clone px1, isolated
by screening a randomly primed HeLa cell plasmid cDNA li-
brary with a PCR-generated 240-bp fragment of the 59-region of
lz9. Together, all of the clones (Fig. 3) comprise 7.7 kb of cDNA,
as determined by nucleotide sequencing. Three of the cDNA
FIG. 1. Intracellular localization of autoantigens by indirect
immunofluorescence. Human Hep2 cells were stained by indirect
immunofluoresence with autoimmune serum 1 (a) and autoimmune
serum 2 (b) or with autoantibodies from serum 1 eluted from clone lg5
(c) or from an irrelevant lgt11 clone (d). Magnifications: a, 3 1000; b, 3
400; c, 3 800; d, 3 500.
FIG. 2. Immunoblot analysis of cell extracts and bacterial fu-
sion protein with autoimmune serum 2. HeLa cell proteins (A) and
total proteins from isopropyl-1-thio-b-D-galactopyranoside-treated E.
coli DH1 cells transformed with recombinant pGEX-clone lg5 autoan-
tigen (B) were separated under reducing conditions on a 5 or 7.5%
polyacrylamide gel, respectively, and transferred to nitrocellulose mem-
branes. Membranes were incubated with autoimmune serum 2 (AIS) or
normal human serum (NHS) followed by peroxidase-conjugated anti-
human immunoglobulin. Bound immunoglobulin was detected by En-
hanced Chemiluminesence.
FIG. 3. Map of p230 cDNA clones. Clones lg2, lg5, lg7, and lg12
were isolated from a lgt11 HeLa cell cDNA library by immunoscreening
with autoimmune serum 1. A lZAP hepatoma cDNA library was
screened with lg5 yielding clones lz2 and lz6; screening the same
library with lz6 resulted in clones lz7a and lz8a, which also showed
positive hybridization with lg5. The lZAP Hepatoma cDNA library was
also screened with a 300-bp fragment of lg7 resulting in lz7, lz8, and
lz16, while a 45-bp segment of lz6 identified lz9. Finally, a PCR-
generated fragment of the 59 region of lz9 was used to screen a pUEX
HeLa cell cDNA plasmid library, identifying clone px1.


























clones, namely px1, lz9, and lz16, collectively span the entire
7.7-kb cDNA.
Northern analysis showed that the three clones, px1, lz9,
and lz16 all hybridized with a similar sized transcript from
HeLa cell poly(A)1 RNA of about 7.7 kb (Fig. 4a). To confirm
that the overlapping clones shown in Fig. 3 were derived from
the same transcript, reverse transcriptase PCR was carried out
using total RNA isolated from HeLa cells and oligonucleotide
primers as indicated in Fig. 4b. A 3.2-kb product was obtained
using primers P1 and P2, and a 4.7-kb product was generated
using primers P3 and P4; the sizes of these PCR products were
in accordance with that expected from the nucleotide sequence
of the clones. The identity of the PCR products was confirmed
by Southern blot analysis using internal probes. The P1/P2
product was probed with a 1.3-kb fragment from clone px1 and
the P3/P4 product with the above mentioned 45-mer (Fig. 4b).
Taken together, our data imply that we have isolated a full-
length cDNA encoding p230.
The clones shown in Fig. 3 gave identical sequences in the
overlap regions. The nucleotide sequence reported here was
verified by either sequence of both strands of a cDNA clone,
identical sequences from at least one other independent clone,
or from reverse transcriptase PCR products. However, two
small differences were detected in the three 39 clones. These
differences comprised a 21-bp stretch (nucleotide 6592–6612)
present in clones lz7 and lz8, but absent in lz16 and a 63-bp
stretch (nucleotide 6950–7012) present in lz7 but absent from
clones lz16 and lz8 (Fig. 5). The absence of the 21 nucleotides
does not disrupt the open reading frame but results in the loss
of the amino acids VTIMELQ, while the absence of the 63
nucleotides results in insertion of an alternative stop codon and
the amino acid sequence of p230 ending in SWLRSSS rather
than FTSPRSGIF. Reverse transcriptase PCR using oligonu-
cleotide primers P4 and P5 resulted in two products of 1.5 and
1.6 kb, sizes consistent with the 63- and 21-bp insertion and
deletion (Fig. 6). There is a unique HincII site in the 63-bp
insertion, and as expected, the 1.6-kb PCR product was suscep-
tible to HincII digestion, giving the expected fragments of 0.98
and 0.64 kb. These results indicate the presence of alterna-
tively spliced mRNAs derived from the same gene. Whether
these different mRNAs represent regulated splicing events or
products from inaccurate splicing is not known.
Sequence Analysis—The nucleotide sequence of p230 cDNA
comprises 7695 bp and contains an open reading frame of 6690
bp (Fig. 6). The open reading frame spans an in-frame ATG
initiation codon at nucleotide position 286 and a TGA termina-
tion codon at position 6976. A second potential ATG initiation
codon is located at nucleotide 388. Both initiation codons have
a purine residue 3 bases 59 upstream of the ATG, representing
favorable translation initiation sites (32). Based on the linear
scanning model of translation initiation (33), the first AUG
FIG. 4. A, Northern blot analysis. HeLa cell poly (A)1 RNA was size
fractionated by formaldehyde gel electrophoresis, transferred to Hy-
bond N1 membranes and hybridized with 32P-labeled cDNA from clone
px1. After washing the membrane and visualizing the signal by auto-
radiography, the 32P-labeled DNA was stripped from the membrane, as
described under “Experimental Procedures,” and the membrane re-
probed with 32P-labeled DNA from clone lz9. A separate membrane was
probed with 32P-labeled DNA from clone lz16. B, reverse transcriptase
PCR and Southern blot analysis. The three clones, px1, lz9, and lz16,
which span the full length of the p230 cDNA overlap as indicated. To
determine if the three clones are derived from the same mRNA, total
RNA from HeLa cells was reverse transcribed, and the cDNA amplified
using oligonucleotide primers P1 and P2 or P3 and P4. The expected
sizes of the products are indicated. Incubations were also carried out in
the absence of either RNA or reverse transcriptase. PCR products were
analyzed by Southern blotting using independent internal cDNA
probes, as described under “Experimental Procedures.” The generation
of PCR products of the expected size confirms the relationship of these
overlapping clones.
FIG. 5. Identification of two p230 mRNA species. A, nucleotides
6592–6612 are present (f) in clones lz7 and lz8, but absent (M) from
clone lz16. Nucleotides 6950–7012 are present (f) in clone lz7, but
absent (M) from clones lz16 and lz8. The sequence from 6950–7012 (f)
contains an in-frame TGA stop codon and a HincII restriction site. P5
(18-mer) and P4 (24-mer) are oligonucleotides used for reverse tran-
scriptase PCR to assess the presence of more than one p230 transcript.
The expected sizes of the PCR products are indicated. B, total RNA from
HeLa cells was reverse transcribed using oligo(dT), and the resulting
cDNA were amplified using primers P4 and P5. The PCR product was
divided into two, with one-half digested with HincII. Samples were
separated by agarose gel electrophoresis and visualized by ethidium
bromide staining. Incubations were also carried out in the absence of
either RNA or reverse transcriptase, as indicated.


























FIG. 6. cDNA and predicted amino acid sequence of p230. Nucleotide sequence of p230 is shown, together with the predicted sequence of
the encoded polypeptide. Proline-rich regions of the predicted polypeptide (see text; domains 1 and 3) are shaded and the granin signature is boxed.





















































initiation codon would be expected to be the dominant signal.
The TGA codon is followed by a polyadenylation signal
AATAAA (34) at position 7660 and a poly(A) tail from position
7679 to 7694.
The open reading frame encodes a putative polypeptide of
2230 amino acids with a predicted molecular weight of 261,126
Da and a pI of 5.16. The amino acid composition of this putative
polypeptide is rich in glutamic acid (16.6%), lysine (12.7%),
leucine (12.5%), and glutamine (10.1%) residues. Comparison
with the GenBank™ data base reveals regions of p230, which
are identical or nearly identical to 15 previously isolated par-
tial cDNA clones of no known function. A list of these loci
together with the corresponding regions of identity in p230 is
given in Table I.
Comparison of the translated amino acid sequence of p230
with the translated GenBank™ data base reveals significant
homology (17–27% identity) with many proteins known or pre-
dicted to encode coiled-coil domains. These include various
conventional and nonconventional myosins, tropomyosins, cy-
tokeratins, vimentin, neurofilaments, laminin, hemeolytic
streptococcal M proteins, dystrophin, the Golgi proteins golgin-
95, golgin-160, and giantin, the Uso1 protein of S. cerevisiae
implicated in endoplasmic reticulum to Golgi transport and its
mammalian homologue p115 or TAP, and the early endosome-
associated protein EEA-1 (35). In addition, this homology was
shared with other structural and motor proteins of the cy-
toskeleton including human cytoplasmic linker protein-170,
kinetocore protein CENP-E, lamins, dynein, and kinesins. In
general, this pattern of identity was scattered throughout the
length of p230, although similar comparisons with translated
GenBank™ sequences using a series of overlapping segments
of p230 revealed that such homology was less pronounced in
the amino-terminal 130 amino acids of p230.
There are two proline-rich domains at the amino terminus of
the putative polypeptide; amino acids 1–117 contains 6.8%
proline residues, while the segment from amino acids 239–270
contains 18.8% proline residues (Fig. 6), suggesting a compact
structure for these domains. The remainder of the protein has
scant proline residues, most of which are clustered at the
extreme carboxyl terminus. Thus, p230 can be divided into four
putative domains on the basis of its proline distribution, i.e.
domain 1 (amino acids 1–117), domain 2 (amino acids 118–
238), domain 3 (amino acids 239–270), and domain 4 (amino
acids 271-2230).
These analyses are consistent with the two proline-rich do-
mains having a high probability of globular structures and an
elongated structure for the intervening domains 2 and 4 (36).
These features are supported by results of secondary structure
predictions (Fig. 7), which suggest a predominantly a-helical
structure for p230 with the exception of the proline-rich do-
mains 1 and 3. Analyses of hydrophilicity (Fig. 7) suggest a
predominantly hydrophilic structure, with no evidence for a
hydrophobic transmembrane domain, consistent with biochem-
ical data reported by Kooy et al. (13). Charge plots (not shown)
show no evidence for discrete acidic or basic domains.
The above features raised the possibility that p230 adopts a
coiled-coil structure, stabilized by heptad repeats. A search for
these structures was performed using the method of Lupas et
al. (26). The results of this analysis (Fig. 8a) reveal an extraor-
dinarily high level of heptad repeats in domains 2 and 4, which
predict a coiled-coiled structure with a high degree of confi-
dence. Detailed sequence analysis of the longest of these re-
gions is shown in Fig. 8b, which shows a run of 31 heptad
repeats extending over 245 amino acids with four heptad
frame-shifts. In common with various fibrous coiled-coil pro-
teins (37, 38), this region shows a high frequency of apolar
residues in positions a (75%) and d (52%) of the heptads and
the absence of acidic residues in these positions. The preference
for leucine over isoleucine at the d position suggests that the
protein has a dimeric rather than a trimeric quaternary struc-
ture (39, 40). This region also shares with the fibrous proteins
a high frequency (54.9%) of charged residues in the outer po-
sitions (b, c, e, f, and g), with only 14.3% of residues in these
positions being apolar. However, in contrast to the fibrous
proteins, this region has a relatively high number of lysine and
arginine residues in the d position, which, together with the
concomitant reduction in apolar residues at this position and
the presence of other discontinuities including frameshifts and
“stutter residues,” would be expected to confer marginal stabil-
ity on the coiled-coil (36).
p230 has multiple consensus motifs for tyrosine phosphoryl-
ation, protein kinase C phosphorylation, casein kinase II phos-
phorylation, cAMP/cGMP phosphorylation, N-myristoylation,
TABLE I
Sequences present in GenBank™ that are homologous to p230
The FASTA program (23) was used to search the GenBank™ data-
base for loci that are homologous to p230. The table lists the GenBank™
loci that were identical or nearly identical to p230, together with the
region of p230 to which homology was shared and the length of the
region of homology. The percentage identity of each locus with the
homologous segment of p230 is also shown.
Locus name Region of identity in p230 Size of homologousregion % Identity
bp
R32028 Nucleotides 8–376 369 91.3
R22854 Nucleotides 14–372 359 89.4
B21241 Nucleotides 14–375 362 92.3
R63927 Nucleotides 15–279 265 97.4
T91725 Nucleotides 26–376 351 98.6
M85542 Nucleotides 37–248 212 96.7
HS721PMR Nucleotides 1853–2434 582 99.8
T10747 Nucleotides 4455–4658 204 96.6
T50957 Nucleotides 4982–5294 313 95.6
HHEA86R Nucleotides 5915–6306 392 100
R32081 Nucleotides 7058–7413 356 95.1
R21240 Nucleotides 7140–7452 313 95.0
R64018 Nucleotides 7140–7515 376 98.2
R22853 Nucleotides 7170–7470 301 92.5
HUMGS01825 Nucleotides 7455–7681 227 100
FIG. 7. Secondary structure predictions for p230. Top panel,
hydrophilicity profile of p230 using Kyte-Doolittle hydropathy scale
with a window of 7 (49). Positive values denote hydrophilic regions that
may be exposed on the outside of p230. Bottom panel, a summary of
secondary structure predictions using the methods of Chou-Fasman
(50–53) (CF, light shaded bars) and Robson-Garnier (54, 55) (RG, dark
shaded bars) with a hydrophilicity window size of 11 is shown, together
with a composite where both Chou-Fasman and Robson-Garnier pre-
dictions are in agreement (CfRg, black shaded bars). The presence of a
bar indicates regions of the protein predicted to form a-helices,
b-pleated sheet, or reverse turns by each of the methods used. These
plots were generated using the MacVector program (International
Biotechnologies Inc.).


























and N-glycosylation. It is not known at present how many of
these motifs are utilized; however, p230 appears to be devoid of
N-glycans (13), consistent with location of the protein on the
cytoplasmic face of Golgi membranes. p230 also contains be-
tween amino acids 538 and 546 the sequence ESLALEELEL, a
motif found in otherwise diverse members of the granin (chro-
mogranin/secretogranin) family of acidic proteins found in the
secretory granules of neuroendocrine cells. A search of the
translated GenBank™ data base revealed that in addition to
chromogranins, this region and its immediate flanking se-
quence showed homology with a number of proteins involved in
subcellular compartmentalization and motor functions, includ-
ing flagellin, calnexin, the Golgi protein giantin, b8-tubulin,
neurofilament L, caldesmon, chromokinesin, and with the hu-
man microtubule-associated protein E-MAP-115. No known
microtubule binding motifs were found in p230.
Chromosomal Localization—Using lg5 clone as a probe, in-
dividual grains recorded on a cumulative idiogram revealed a
significant accumulation of signal on a region of the short arm
of human chromosome 6, assigning the probe to 6p12–22. Fig.
9a shows a diagrammatic presentation of the genomic distri-
bution of grains observed in 70 metaphase spreads on one slide.
An enlarged diagram of the grains recorded on chromosome 6,
showing a peak at 6p12–22, together with photographs of a
silver grain located at the specific site of hybridization, are
shown in Fig. 9b.
FIG. 8. A, prediction of coiled-coil seg-
ments of p230. The lower panel is a histo-
gram of the probability of forming a
coiled-coil structure according to the
method of Lupas et al. (26). p . 0.9 are
significant. Bars above the histogram in-
dicate which of the possible seven
“frames” the heptad repeats follow for
each region of the protein with P.0.5 for
formation of a coiled-coil structure. The
presence of numerous “frameshifts” pro-
vides evidence of discontinuities in the
coiled coil structure (see text). B, primary
sequence of the longest uninterrupted re-
gion of heptad repeats from p230. The
amino acid sequence of p230 from position
1460 to 1704 is plotted to show the posi-
tion of each residue within a heptad re-
peat of the form abcdefg (38). Apolar res-
idues at positions a and d are shown in
boldface.
FIG. 9. Chromosomal localization of
human p230 gene. A, diagram showing
the grain distribution in 70 metaphase
spreads on one slide following hybridiza-
tion with 3H-labeled DNA from clone lg5;
B, an enlargement of grains recorded on
chromosome 6 together with photographs
showing silver grains on G-banded chro-
mosome 6.



























The cDNA clones we have isolated encode the full-length
p230 Golgi protein for the following reasons. First, autoanti-
bodies, affinity-purified from clones lg2, lg5, lg7, and lg12,
gave immunofluorescence staining of the Golgi apparatus of
Hep2 cells. Second, rabbit antibodies raised against a bacterial
fusion protein incorporating clone lg5 not only stained the
Golgi apparatus by immunofluorescence and immunoelectron
microscopy, but also immunoblotted and immunoprecipitated a
230-kDa protein from HeLa cells (13). Third, cDNAs of clones
px1, lz9, and lz16 together span 7.7 kb, in agreement with the
size of the mRNA obtained from Northern blots; and fourth,
reverse transcripase PCR demonstrated that these three clones
were derived from the same transcript.
The deduced amino acid sequence of p230 suggests a hydro-
philic, modestly acidic protein capable of forming a dimeric
coiled coil structure. While most (.90%) of the protein is pre-
dicted to form this structure, the extreme amino-terminal 130
amino acids and a segment between amino acids 239 and 270
are predicted to form compact structures consistent with glob-
ular regions. While it is well established that stable static
coiled coils can serve as multimerization motifs in structural
proteins, dynamic coiled-coil formation can play a central role
in generation of conformational changes resulting in dramatic
movements of one part of a protein relative to another. Such
coiled-coil regions have been implicated in the function of the
nonclaret disjunctional kinesin-related microtubule motor pro-
tein, which translocates on microtubules toward their minus
ends and is required for proper chromosome segregation in
Drosophila oocytes (41). This protein has a central stalk region
consisting of heptad repeats predicted to form coiled-coils. A
mutant that lacks the amino-terminal third of the coiled-coil
stalk exhibits partial loss of function, having a translocation
velocity and torque generation similar to wild-type protein, but
only partially rescues a null mutant for chromosome missegre-
gation. A similar effect has been reported for a cytoplasmic
myosin II protein partially deleted for its coiled-coil tail (42). In
this case, the mutant protein is expressed at a level comparable
with the wild-type protein and translocates on actin filaments
in vitro with the same velocity as wild-type protein, but in spite
of this, exhibits frequent failure of cytokinesis in vivo. Of par-
ticular interest is the loss of function reported for partial dele-
tions of the coiled-coil domain of the yeast Uso1 protein (43), a
protein involved in vesicular transport, where such mutations
are temperature-sensitive lethal, resulting in a severe defect of
endoplasmic reticulum to Golgi protein transport at the non-
permissive temperature. It has been suggested that a key
structural feature of coiled-coils that participate in conforma-
tional changes is the presence of regions of marginal stability
caused by discontinuities in heptad repeats of the coiled coil as
a result of deletions, insertions, or out-of-frame residues (44).
The presence of extensive regions of this type in p230 raises the
possibility of dynamic coiled-coil formation, which could play a
role in regulation of multimerization or in induction of confor-
mational changes in the protein. Dramatic conformational
changes have been found to occur in other coiled-coil proteins
involved in membrane fusion events (for review, see Ref. 44).
p230 also has a short region of homology to the conserved
carboxyl-terminal domain of the granin (chromogranin/secre-
togranin) family of proteins, a diverse group of acidic proteins
present in secretory granules of endocrine and neuroendocrine
cells (for review, see Ref. 45). Granins are suggested to be
precursors of several peptide hormones and to regulate proteo-
lytic processing and selective aggregation of secretory proteins
in the trans-Golgi network of neuroendocrine cells (46). Only
one short region at the carboxyl terminus is shared among the
granins. This region bears the consensus sequence E(N/
S)LX(A/D)X(D/E)XEL which is closely related to a sequence
found in p230 (Fig. 6). A short region of the carboxyl terminus
of chromogranin A, containing the granin motif, may be respon-
sible for pH-regulated multimerization of the protein (47) and,
together with the pH-dependent association of chromogranin A
with integral membrane proteins of the secretory vesicle, sug-
gests a role for chromogranins A in the sorting of these mem-
brane proteins during vesicle biogenesis in the trans-Golgi
network (48). However, the relevance of this motif in p230 is
unclear since p230 is orientated on the cytosolic side of Golgi
membranes.
There is an increasing number of proteins implicated in
vesicular transport that have extensive coiled-coil domains.
These domains have potential for dynamic interactions associ-
ated with this highly complex process. The potential dynamic
coiled-coil structure of p230, its localization to the trans-Golgi
network,3 and sensitivity to brefeldin A (13) suggest that p230
may have a key role in vesicular transport from this distal
Golgi compartment.
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